“US Biosimilars” ACI

April 20, 2015

On April 20 and 21, Steptoe partners John Molenda and Tom Filarski will participate in ACI’s “US Biosimilars” in Munich.  Mr. Molenda will be participating in the panel “Obtaining Adequate Patent Protection in the US: Factoring Key Cases into Your Biosimilars Patent Strategy.”  Mr. Filarski will participate in the panel : “Incorporating Inter Partes Review and New USPTO Procedures Into Branded and Biosimilar Litigation Strategies.”

More information can be found at ACI.